Antireflux surgery for Barrett's oesophagus.
DOI: 10.1046/J.1445-1433.2003.02569.X
关键词: Non acid reflux 、 Dysplasia 、 Barrett's oesophagus 、 Cancer 、 Gastroenterology 、 Intestinal metaplasia 、 Reflux 、 Medicine 、 Surgery 、 Antireflux surgery 、 In patient 、 Internal medicine
摘要: Barrett's oesophagus is usually the result of severe reflux disease. Relief symptoms primary aim treatment in patients with who do not have high-grade dysplasia. Some studies medium-term (2-5 years) follow up show that antireflux surgery can provide good or excellent symptom control, normal oesophageal acid exposure, more than 90% oesophagus. Antireflux surgery, but medical therapy, also reduce duodenal nonacid to levels. There no conclusive evidence prevent development dysplasia cancer, it reliably induce regression dysplasia, and should therefore remain a surveillance programme after operation. data suggest intestinal metaplasia (IM) disease IM. The combination plus an endoscopic ablation procedure promising for low-grade
sci-hub.se 参考文章(238)
D. O. Castell, David A Katzka, Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. The American Journal of Gastroenterology. ,vol. 89, pp. 989- 991 ,(1994)
Glyn G. Jamieson, David I. Watson, Optimal Surgical Therapy for Anti Reflux Disease Springer, Dordrecht. pp. 137- 147 ,(2001) , 10.1007/978-94-017-0829-6_10
Oehlke M, Helfand M, Lieberman Da, Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. The American Journal of Gastroenterology. ,vol. 92, pp. 1293- 1297 ,(1997)
Post-cimetidine Surveillance for up to Ten Years: Incidence of Carcinoma of the Stomach and Oesophagus QJM: An International Journal of Medicine. ,vol. 78, pp. 13- 19 ,(1991) , 10.1093/OXFORDJOURNALS.QJMED.A068520
R S Sandler, S Murray, M Gottfried, G M Eisen, The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. The American Journal of Gastroenterology. ,vol. 92, pp. 27- 31 ,(1997)
V Velanovich, J R Gusz, F V Tapia, M A Harkabus, S R Vallance, Quality of life scale for gastroesophageal reflux disease. Journal of The American College of Surgeons. ,vol. 183, pp. 217- 224 ,(1996)
Camargo E, Sampliner Re, Sharma P, Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. The American Journal of Gastroenterology. ,vol. 92, pp. 582- 585 ,(1997)
Hubert J. Stein, Sebastian Hoeft, Tom R. DeMeester, Functional foregut abnormalities in Barrett's esophagus The Journal of Thoracic and Cardiovascular Surgery. ,vol. 105, pp. 107- 111 ,(1993) , 10.1016/S0022-5223(19)33854-1
Alan J. Cameron, Alan R. Zinsmeister, David J. Ballard, J.Aidan Carney, Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population-based clinical and autopsy findings Gastroenterology. ,vol. 99, pp. 918- 922 ,(1990) , 10.1016/0016-5085(90)90607-3
Drewitz Dj, Garewal Hs, Sampliner Re, The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. The American Journal of Gastroenterology. ,vol. 92, pp. 212- 215 ,(1997)